All posts by : Felistas

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

New research published in the New England Journal of Medicine has shown a single dose of the influenza vaccine is sufficient for people with blood cancer who have not had a transplant.

The World Health Organization appealed Thursday for $1.5 billion for emergency operations this year, warning that conflict, climate change, epidemics and displacement had converged to create an “unprecedented global health crisis”.

Today, the American Cancer Society (ACS) released Cancer Statistics, 2025, the organization’s annual report on cancer facts and trends. The new findings show the cancer mortality rate declined by 34% from 1991 to 2022 in the United States, averting approximately 4.5 million deaths. However, this steady progress is jeopardized by increasing incidence for many cancer types, especially among women and younger adults, shifting the burden of disease.

Radiotherapy has been a cornerstone of cancer treatment for decades, offering a targeted approach to treat tumors. Yet, as effective as it is, it often causes unwanted damage to neighboring healthy tissues—which can lead to many side-effects.

A small team of psychiatrists at Columbia University, in the U.S., has found that despite an increase in the use of teletherapy over the past several years by both psychotherapists and their patients, access to such care has not increased for those who cannot afford to pay for it.

A rather historic U.S. Food and Drug Administration (FDA) proposal aims to make cigarettes and other tobacco products far less addictive by reducing their nicotine content.

Young nearsighted kids who wear bifocal contact lenses that slow uncoordinated eye growth do not lose the benefits of the treatment once they stop wearing the lenses, new research shows.

The overwhelming majority of those in New York City who obtained a naloxone kit to counteract opioid overdose had a high need for the drug, according to a study by Weill Cornell Medicine investigators and the New York City Department of Health and Mental Hygiene.

For early postmenopausal women, zoledronate administered at baseline and five years is effective for preventing morphometric vertebral fracture, according to a study published in the Jan. 16 issue of the New England Journal of Medicine.